* If you want to update the article please login/register
90 patients with demodectic blepharitis-related dry eyes were selected, and they were divided into experimental group 1, experimental group 2, and control group. The results revealed that after treatment, the symptoms of group E1 and group E2 were significantly lower than those before treatment, and the differences were statistically significant. The groups E1 and E2's clinical signs after treatment were remarkably different from those before treatment. Those of group E1 showed the largest differences in comparison to the scores of clinical signs and clinical signs after treatment, indicating the best treatment result. With the new watershed technique, the treatment of demodectic blepharitis may have been enhanced, according to In conclusion, microscopic images mixed with meibomian gland microprobe provided the best result in the treatment of demodectic blepharitis in comparison to the traditional drug heat compress.
Source link: https://doi.org/10.1155/2022/4389659
Methods, Inc. This prospective, open-blinded controlled trial of bevacizumab eye drops in patients with meibomian gland dysfunction (Aims) was conducted in conjunction with a standard lid hygiene treatment at King Chulalongkorn Memorial Hospital's Chula Refractive Surgery Center in conjunction with standard lid hygiene in patients with meibomian gland dysfunction -associated posterior blepharitis. Patients were either randomly assigned to receive lid hygiene plus 0. 05% bevacizumab eye drops or a single intra-MG injection of 2. 5% bevacizumab. Results were not significant differences between groups in both telangiectasia grade and LMNA, among other measures; however, in the eye drop group, only telangiectasia grade and LMNA improved relative to baseline; however, in the eye drop group, only the dialangiectasia grade and LMNA were determined before and three months after treatment; however, in the eye drop group, only the telangiectasia grade and LMNA were analyzed.
Source link: https://doi.org/10.3389/fmed.2022.895418
A retrospective, noncomparative study of 17 blepharitis patients aged between 5 and 16 years old was conducted to investigate the safety and effectiveness of low fluence-infused light for treating pediatric patients with moderate to severe blepharitis and to assess potential causes associated with the recovery of meibomian glands dropout. In conclusion, low fluence IPL appears to be a safe and effective alternative to severe pediatric blepharitis, and MG dropout in younger patients is prone to recovery.
Source link: https://doi.org/10.3390/jcm11113080
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions